Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer

ClinicalTrials.gov ID: NCT00114231

Public ClinicalTrials.gov record NCT00114231. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy, such as capecitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Oxaliplatin may make tumor cells more sensitive to radiation therapy. Giving capecitabine and oxaliplatin together with radiation therapy before surgery may shrink the tumor so it can be removed. PURPOSE: This phase II trial is studying how well giving capecitabine and oxaliplatin together with radiation therapy works in treating patients who are undergoing surgery for stage I rectal cancer.

Study identification

NCT ID
NCT00114231
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
90 participants

Conditions and interventions

Interventions

Drug · Procedure · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2006 (Type not available)
Primary completion
Dec 2013 (Actual)
Completion
Dec 2014 (Actual)
Last update posted
Mar 29, 2018

2006 – 2014

United States locations

U.S. sites
67
U.S. states
20
U.S. cities
49
Facility City State ZIP Site status
Mayo Clinic Scottsdale Scottsdale Arizona 85259-5499 —
Cancer Care Center at John Muir Health - Concord Campus Concord California 94524-4110 —
City of Hope Comprehensive Cancer Center Duarte California 91010-3000 —
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90089-9181 —
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange California 92868 —
John Muir/Mt. Diablo Comprehensive Cancer Center Walnut Creek California 94598 —
St. Vincent's Medical Center Bridgeport Connecticut 06606 —
Praxair Cancer Center at Danbury Hospital Danbury Connecticut 06810 —
Mayo Clinic - Jacksonville Jacksonville Florida 32224 —
Tampa General Hospital Tampa Florida 33606 —
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia 31403-3089 —
Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler Savannah Georgia 31405 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove Indiana 46107 —
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202-5289 —
William N. Wishard Memorial Hospital Indianapolis Indiana 46202 —
Reid Hospital & Health Care Services Richmond Indiana 47374 —
Ochsner Cancer Institute at Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
Altru Cancer Center at Altru Hospital Grand Forks North Dakota 58201 —
Grandview Hospital Dayton Ohio 45405 —
Good Samaritan Hospital Dayton Ohio 45406 —
David L. Rike Cancer Center at Miami Valley Hospital Dayton Ohio 45409 —
Samaritan North Cancer Care Center Dayton Ohio 45415 —
Veterans Affairs Medical Center - Dayton Dayton Ohio 45428 —
CCOP - Dayton Dayton Ohio 45429 —
Blanchard Valley Medical Associates Findlay Ohio 45840 —
Middletown Regional Hospital Franklin Ohio 45005-1066 —
Wayne Hospital Greenville Ohio 45331 —
Charles F. Kettering Memorial Hospital Kettering Ohio 45429 —
UVMC Cancer Care Center at Upper Valley Medical Center Troy Ohio 45373-1300 —
Clinton Memorial Hospital Wilmington Ohio 45177 —
Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia Ohio 45385 —
Integris Oncology Services Oklahoma City Oklahoma 73112 —
Natalie Warren Bryant Cancer Center at St. Francis Hospital Tulsa Oklahoma 74136 —
Providence Cancer Center at Providence Portland Medical Center Portland Oregon 97213-2967 —
Knight Cancer Institute at Oregon Health and Science University Portland Oregon 97239-3098 —
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest Allentown Pennsylvania 18105 —
UPMC Cancer Center at Beaver Medical Center Beaver Pennsylvania 15009 —
UPMC Cancer Center at Jefferson Regional Medical Center Clairton Pennsylvania 15025 —
UPMC Cancer Center - Arnold Palmer Pavilion Greensburg Pennsylvania 15601 —
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850 —
UPMC Cancer Center at the John P. Murtha Pavilion Johnstown Pennsylvania 15901 —
UPMC - Moon Moon Township Pennsylvania 15108 —
UPMC Cancer Center - Natrona Heights Natrona Heights Pennsylvania 15065 —
Jameson Memorial Hospital - North Campus New Castle Pennsylvania 16105 —
Fox Chase Cancer Center - Philadelphia Philadelphia Pennsylvania 19111-2497 —
Allegheny Cancer Center at Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
UPMC - Shadyside Pittsburgh Pennsylvania 15213-2582 —
UPMC Cancer Center at Magee-Womens Hospital Pittsburgh Pennsylvania 15213 —
UPMC Cancer Center at UPMC Presbyterian Pittsburgh Pennsylvania 15213 —
UPMC Cancer Center at UPMC St. Margaret Pittsburgh Pennsylvania 15215 —
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh Pennsylvania 15224-1791 —
UPMC Cancer Centers Pittsburgh Pennsylvania 15232 —
UPMC Cancer Center at UPMC Passavant Pittsburgh Pennsylvania 15237 —
St. Clair Memorial Hospital Cancer Center Pittsburgh Pennsylvania 15243 —
UPMC Cancer Center at UPMC Northwest Seneca Pennsylvania 16346 —
Washington Hospital Cancer Center Washington Pennsylvania 15301 —
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-6838 —
M. D. Anderson Cancer Center at University of Texas Houston Texas 77030-4009 —
Methodist Hospital Houston Texas 77030 —
Surgical Oncology Associates Newport News Virginia 23606 —
Providence Cancer Center at Sacred Heart Medical Center Spokane Washington 99204 —
Providence Cancer Center at Holy Family Hospital Spokane Washington 99207 —
United Hospital Center Clarksburg West Virginia 26301 —
Edwards Comprehensive Cancer Center at Cabell Huntington Hospital Huntington West Virginia 25701 —
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison Wisconsin 53792-6164 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00114231, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2018 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00114231 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →